Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Emory University
With
Medtronic
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject is able and willing to sign and date the Patient Consent Form.
Subject is 18 years of age or older.
Subject is expected to remain available for at least 12 months of follow- up visits.
Subject is willing to comply with the protocol, including follow-up visits, medication compliance, carelink transmissions, and randomization assignment.
Subject has a CHADS2 score of ≥ 1.
Subject is hospitalized post isolated CABG or is within 72 hours post hospital discharge from a CABG procedure.
Subject has no previous history of AF and has developed new-onset postoperative atrial fibrillation according to the established STS definition, which defines it as the occurrence of POAF or atrial flutter requiring treatment (i.e. beta-blockers, calcium-channel blockers, amiodarone, anticoagulation, or cardioversion).
You may not be if
Subject has a medically documented history of paroxysmal or persistent atrial fibrillation or atrial flutter.
Subject is pregnant.
Subject is enrolled or planning to participate in a concurrent drug and/or device study during the course of this study that would confound study results as determined by the study physician.
Subject has previously or is scheduled to undergo valve repair or valve replacement during the course of the study.